June 19, 2024 By Miranda Schmalfuhs DIA 2024: Machine Learning and Simulations to Facilitate Clinical Trials In a session at the 2024 DIA Global Annual meeting in San Diego, CA, Raviv Pryluk, CEO & co-founder, PhaseV;…
A recent report from Accenture analyzes the value and impact AI can have on drug research and development. By Veronica Salib, Associate Editor Published: 22 Jul 2024 Last month, Accenture published a report titled “Reinventing R&D in the age…
Contributed Commentary by Wing Lon Ng, Director of AI Engineering, IQVIA July 19, 2024 | The rapid advancements in artificial intelligence, particularly generative AI (GenAI), are enabling broader technology acceleration and driving a significant transformation in…
By Andrew Bolt, principal, and Amy Cheung, principal, Deloitte Consulting LLP In today’s challenging economic environment, leaders in life sciences are often faced with the difficulty of executing flexible and adaptable clinical trials that can serve the…
Hitesh Chopra, PhD,a Annu, PhD,b Dong K. Shin, PhD,b Kavita Munjal, PhD,c Priyanka, PhD,d Kuldeep Dhama, PhD,e and Talha B. Emran, PhDf,g Author information Article notes Copyright and License information PMC Disclaimer Associated Data Data Availability Statement Abstract Clinical trials are the essential assessment for…